154 related articles for article (PubMed ID: 23368102)
1. Biologically active 4-thiazolidinones: a review of QSAR studies and QSAR modeling of antitumor activity.
Devinyak O; Zimenkovsky B; Lesyk R
Curr Top Med Chem; 2012; 12(24):2763-84. PubMed ID: 23368102
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
Aboalhaija NH; Zihlif MA; Taha MO
Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
[TBL] [Abstract][Full Text] [Related]
3. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new 4-thiazolidinone derivatives.
Güzel O; Salman A
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1015-23. PubMed ID: 19624255
[TBL] [Abstract][Full Text] [Related]
5. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
[TBL] [Abstract][Full Text] [Related]
6. Facile synthesis and quantitative structure-activity relationship study of antitumor active 2-(4-oxo-thiazolidin-2-ylidene)-3-oxo-propionitriles.
Hanna MM; George RF
Chem Pharm Bull (Tokyo); 2012; 60(9):1195-206. PubMed ID: 22976330
[TBL] [Abstract][Full Text] [Related]
7. Development of Predictive QSAR Models of 4-Thiazolidinones Antitrypanosomal Activity Using Modern Machine Learning Algorithms.
Kryshchyshyn A; Devinyak O; Kaminskyy D; Grellier P; Lesyk R
Mol Inform; 2018 May; 37(5):e1700078. PubMed ID: 29134756
[TBL] [Abstract][Full Text] [Related]
8. Novel thiazolidines: Synthesis, antiproliferative properties and 2D-QSAR studies.
Singh RP; Aziz MN; Gout D; Fayad W; El-Manawaty MA; Lovely CJ
Bioorg Med Chem; 2019 Oct; 27(20):115047. PubMed ID: 31471102
[TBL] [Abstract][Full Text] [Related]
9. Study of antineoplastic action of novel isomeric derivatives of 4-thiazolidinone.
Chumak VV; Fil MR; Panchuk RR; Zimenkovsky BS; Havrylyuk DY; Lesyk RB; Stoika RS
Ukr Biochem J; 2014; 86(6):96-105. PubMed ID: 25816610
[TBL] [Abstract][Full Text] [Related]
10. QSAR Studies to Predict Activity of HSP90 Inhibitors.
Patil VM; Masand N; Gupta SP; Blagg BSJ
Curr Top Med Chem; 2021; 21(25):2272-2291. PubMed ID: 34635040
[TBL] [Abstract][Full Text] [Related]
11. Utility of L-norephedrine in the semisynthesis of novel thiourea and thiazolidine derivatives as a new class of anticancer agents.
Ghorab MM; Alqasoumi SI; Abdel-Kader MS; Alsaid MS
Acta Pol Pharm; 2014; 71(4):615-23. PubMed ID: 25272887
[TBL] [Abstract][Full Text] [Related]
12. Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
Liu Y; Li F; Wu L; Wang W; Zhu H; Zhang Q; Zhou H; Yan B
Bioorg Med Chem Lett; 2015 May; 25(9):1971-5. PubMed ID: 25827524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of thiazolidin-4-ones clubbed with quinazolinone.
Deep A; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Majeed AB
Curr Top Med Chem; 2013 Aug; 13(16):2034-46. PubMed ID: 23895092
[TBL] [Abstract][Full Text] [Related]
14. Synthetic and medicinal perspective of thiazolidinones: A review.
Kaur Manjal S; Kaur R; Bhatia R; Kumar K; Singh V; Shankar R; Kaur R; Rawal RK
Bioorg Chem; 2017 Dec; 75():406-423. PubMed ID: 29102723
[TBL] [Abstract][Full Text] [Related]
15. 4-Thiazolidinones: the advances continue….
Tripathi AC; Gupta SJ; Fatima GN; Sonar PK; Verma A; Saraf SK
Eur J Med Chem; 2014 Jan; 72():52-77. PubMed ID: 24355348
[TBL] [Abstract][Full Text] [Related]
16. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Day CW; Smee DF; Grellier P; Lesyk R
Eur J Med Chem; 2013 Aug; 66():228-37. PubMed ID: 23811085
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Anticancer Activity Evaluation of 5-[2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-thiazolidinones.
Buzun K; Kryshchyshyn-Dylevych A; Senkiv J; Roman O; Gzella A; Bielawski K; Bielawska A; Lesyk R
Molecules; 2021 May; 26(10):. PubMed ID: 34065476
[TBL] [Abstract][Full Text] [Related]
20. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
